ELAN
Elanco Animal Health Incorporated$22.26+0.15 (+0.70%)Prev Close$22.09·MCap$11.29B·P/E—·Vol1.79M·Yield—
▲
Buys (12M)
4
$937.9K
▼
Sells (12M)
2
$80.6K
◆
Net Activity
Net Buyer
$857.3K
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Elanco Animal Health Incorporated (ELAN) has been dominated by buying, with 4 insider purchases totaling $937.9K and 2 insider sales totaling $80.6K. The most recent insider transaction was by Kurzius Lawrence Erik (Director), who purchased $213.0K worth of shares on Dec 12, 2025. Elanco Animal Health Incorporated operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $11.29B.
ELAN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Kurzius Lawrence Erik | Director | Buy | 10,000 | $21.30 | $213.0K | 0 |
| Dec 11, 2025 | Modi Rajeev A. | SEE REMARKS | Buy | 4,500 | $21.33 | $96.0K | 0 |
| Dec 11, 2025 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Buy | 22,000 | $21.75 | $478.5K | 0 |
| Dec 11, 2025 | VanHimbergen Robert M | EVP and CFO | Buy | 6,950 | $21.64 | $150.4K | 0 |
| Jul 3, 2025 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 4,346 | $14.64 | $63.6K | 0 |
| Jul 3, 2025 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 1,161 | $14.64 | $17.0K | 0 |
| Apr 3, 2025 | Bettington Timothy J | SEE REMARKS | Sell | 23,558 | $9.72 | $229.0K | 0 |
| Mar 7, 2025 | Kurzius Lawrence Erik | Director | Buy | 20,000 | $10.55 | $211.0K | 0 |
| Mar 5, 2025 | HOOVER R DAVID | Director | Buy | 25,000 | $10.90 | $272.6K | 0 |
| Mar 1, 2025 | Bettington Timothy J | SEE REMARKS | Sell | 3,514 | $11.17 | $39.3K | 0 |
| Mar 1, 2025 | Cabral Ramiro Martin | SEE REMARKS | Sell | 11,749 | $11.17 | $131.2K | 0 |
| Mar 1, 2025 | Correia de Simas Jose Manuel | SEE REMARKS | Sell | 4,747 | $11.17 | $53.0K | 0 |
| Mar 1, 2025 | de Brabander Ellen | SEE REMARKS | Sell | 15,049 | $11.17 | $168.1K | 0 |
| Mar 1, 2025 | Kinard David S | SEE REMARKS | Sell | 7,162 | $11.17 | $80.0K | 0 |
| Mar 1, 2025 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 3,430 | $11.17 | $38.3K | 0 |
| Mar 1, 2025 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 2,356 | $11.17 | $26.3K | 0 |
| Mar 1, 2025 | Modi Rajeev A. | SEE REMARKS | Sell | 6,557 | $11.17 | $73.2K | 0 |
| Mar 1, 2025 | O'Neill Shiv | GC AND CORP SEC | Sell | 3,879 | $11.17 | $43.3K | 0 |
| Mar 1, 2025 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Sell | 75,721 | $11.17 | $845.8K | 0 |
| Mar 1, 2025 | YOUNG TODD S. | SEE REMARKS | Sell | 18,196 | $11.17 | $203.2K | 0 |
| Feb 19, 2025 | Cabral Ramiro Martin | SEE REMARKS | Sell | 30,093 | $11.24 | $338.2K | 207,169 |
| Feb 19, 2025 | Correia de Simas Jose Manuel | SEE REMARKS | Sell | 11,808 | $11.24 | $132.7K | 64,042 |
| Feb 19, 2025 | de Brabander Ellen | SEE REMARKS | Sell | 69,916 | $11.24 | $785.9K | 186,214-27% |
| Feb 19, 2025 | Kinard David S | SEE REMARKS | Sell | 17,968 | $11.24 | $202.0K | 173,935 |
| Feb 19, 2025 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 2,596 | $11.24 | $29.2K | 55,641 |
| Feb 19, 2025 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 2,691 | $11.24 | $30.2K | 49,462 |
| Feb 19, 2025 | Modi Rajeev A. | SEE REMARKS | Sell | 18,737 | $11.24 | $210.6K | 94,619 |
| Feb 19, 2025 | O'Neill Shiv | GC AND CORP SEC | Sell | 2,943 | $11.24 | $33.1K | 26,849 |
| Feb 19, 2025 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Sell | 195,840 | $11.24 | $2.20M | 1,612,848 |
| Feb 19, 2025 | YOUNG TODD S. | SEE REMARKS | Sell | 46,045 | $11.24 | $517.5K | 159,062 |
| Jan 3, 2025 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 351 | $11.98 | $4.2K | 50,212 |
| Jan 3, 2025 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 414 | $11.98 | $5.0K | 48,773 |
| Aug 22, 2024 | Harrington Michael J | Director | Buy | 3,500 | $14.85 | $52.0K | 81,094 |
| Aug 12, 2024 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Buy | 100,000 | $13.01 | $1.30M | 145,000+222% |
| Jul 3, 2024 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 4,345 | $14.13 | $61.4K | 50,563 |
| Jul 3, 2024 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 1,160 | $14.13 | $16.4K | 49,187 |
| May 21, 2024 | DOYLE WILLIAM F | Director | Buy | 15,000 | $16.98 | $254.7K | 76,330 |
| Apr 3, 2024 | Bettington Timothy J | SEE REMARKS | Sell | 23,557 | $15.43 | $363.5K | 106,387 |
| Apr 1, 2024 | Modi Rajeev A. | SEE REMARKS | Sell | 7,509 | $15.97 | $119.9K | 69,763 |
| Mar 8, 2024 | DOYLE WILLIAM F | Director | Buy | 15,000 | $16.30 | $244.5K | 61,330+32% |
| Mar 8, 2024 | Harrington Michael J | Director | Buy | 3,100 | $16.29 | $50.5K | 77,594 |
| Mar 6, 2024 | HOOVER R DAVID | Director | Buy | 20,000 | $16.14 | $322.8K | 185,000 |
| Mar 5, 2024 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Sell | 11,012 | $15.99 | $176.1K | 1,356,455 |
| Mar 1, 2024 | Cabral Ramiro Martin | SEE REMARKS | Sell | 8,909 | $16.03 | $142.8K | 169,048 |
| Mar 1, 2024 | Correia de Simas Jose Manuel | SEE REMARKS | Sell | 3,642 | $16.03 | $58.4K | 49,768 |
| Mar 1, 2024 | de Brabander Ellen | SEE REMARKS | Sell | 9,774 | $16.03 | $156.7K | 114,886 |
| Mar 1, 2024 | Kinard David S | SEE REMARKS | Sell | 5,731 | $16.03 | $91.9K | 149,646 |
| Mar 1, 2024 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 1,921 | $16.03 | $30.8K | 54,908 |
| Mar 1, 2024 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 1,667 | $16.03 | $26.7K | 50,347 |
| Mar 1, 2024 | Modi Rajeev A. | SEE REMARKS | Sell | 3,616 | $16.03 | $58.0K | 77,272 |
Showing 1–50 of 145
1 / 3
ELAN Insider Buying Activity
The following table shows recent insider purchases of Elanco Animal Health Incorporated (ELAN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Kurzius Lawrence Erik | Director | Buy | 10,000 | $21.30 | $213.0K | 0 |
| Dec 11, 2025 | Modi Rajeev A. | SEE REMARKS | Buy | 4,500 | $21.33 | $96.0K | 0 |
| Dec 11, 2025 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Buy | 22,000 | $21.75 | $478.5K | 0 |
| Dec 11, 2025 | VanHimbergen Robert M | EVP and CFO | Buy | 6,950 | $21.64 | $150.4K | 0 |
| Mar 7, 2025 | Kurzius Lawrence Erik | Director | Buy | 20,000 | $10.55 | $211.0K | 0 |
| Mar 5, 2025 | HOOVER R DAVID | Director | Buy | 25,000 | $10.90 | $272.6K | 0 |
| Aug 22, 2024 | Harrington Michael J | Director | Buy | 3,500 | $14.85 | $52.0K | 81,094 |
| Aug 12, 2024 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Buy | 100,000 | $13.01 | $1.30M | 145,000+222% |
| May 21, 2024 | DOYLE WILLIAM F | Director | Buy | 15,000 | $16.98 | $254.7K | 76,330 |
| Mar 8, 2024 | DOYLE WILLIAM F | Director | Buy | 15,000 | $16.30 | $244.5K | 61,330+32% |
| Mar 8, 2024 | Harrington Michael J | Director | Buy | 3,100 | $16.29 | $50.5K | 77,594 |
| Mar 6, 2024 | HOOVER R DAVID | Director | Buy | 20,000 | $16.14 | $322.8K | 185,000 |
ELAN Insider Selling Activity
The following table shows recent insider sales of Elanco Animal Health Incorporated (ELAN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 3, 2025 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 4,346 | $14.64 | $63.6K | 0 |
| Jul 3, 2025 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 1,161 | $14.64 | $17.0K | 0 |
| Apr 3, 2025 | Bettington Timothy J | SEE REMARKS | Sell | 23,558 | $9.72 | $229.0K | 0 |
| Mar 1, 2025 | Bettington Timothy J | SEE REMARKS | Sell | 3,514 | $11.17 | $39.3K | 0 |
| Mar 1, 2025 | Cabral Ramiro Martin | SEE REMARKS | Sell | 11,749 | $11.17 | $131.2K | 0 |
| Mar 1, 2025 | Correia de Simas Jose Manuel | SEE REMARKS | Sell | 4,747 | $11.17 | $53.0K | 0 |
| Mar 1, 2025 | de Brabander Ellen | SEE REMARKS | Sell | 15,049 | $11.17 | $168.1K | 0 |
| Mar 1, 2025 | Kinard David S | SEE REMARKS | Sell | 7,162 | $11.17 | $80.0K | 0 |
| Mar 1, 2025 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 3,430 | $11.17 | $38.3K | 0 |
| Mar 1, 2025 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 2,356 | $11.17 | $26.3K | 0 |
| Mar 1, 2025 | Modi Rajeev A. | SEE REMARKS | Sell | 6,557 | $11.17 | $73.2K | 0 |
| Mar 1, 2025 | O'Neill Shiv | GC AND CORP SEC | Sell | 3,879 | $11.17 | $43.3K | 0 |
| Mar 1, 2025 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Sell | 75,721 | $11.17 | $845.8K | 0 |
| Mar 1, 2025 | YOUNG TODD S. | SEE REMARKS | Sell | 18,196 | $11.17 | $203.2K | 0 |
| Feb 19, 2025 | Cabral Ramiro Martin | SEE REMARKS | Sell | 30,093 | $11.24 | $338.2K | 207,169 |
| Feb 19, 2025 | Correia de Simas Jose Manuel | SEE REMARKS | Sell | 11,808 | $11.24 | $132.7K | 64,042 |
| Feb 19, 2025 | de Brabander Ellen | SEE REMARKS | Sell | 69,916 | $11.24 | $785.9K | 186,214-27% |
| Feb 19, 2025 | Kinard David S | SEE REMARKS | Sell | 17,968 | $11.24 | $202.0K | 173,935 |
| Feb 19, 2025 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 2,596 | $11.24 | $29.2K | 55,641 |
| Feb 19, 2025 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 2,691 | $11.24 | $30.2K | 49,462 |
| Feb 19, 2025 | Modi Rajeev A. | SEE REMARKS | Sell | 18,737 | $11.24 | $210.6K | 94,619 |
| Feb 19, 2025 | O'Neill Shiv | GC AND CORP SEC | Sell | 2,943 | $11.24 | $33.1K | 26,849 |
| Feb 19, 2025 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Sell | 195,840 | $11.24 | $2.20M | 1,612,848 |
| Feb 19, 2025 | YOUNG TODD S. | SEE REMARKS | Sell | 46,045 | $11.24 | $517.5K | 159,062 |
| Jan 3, 2025 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 351 | $11.98 | $4.2K | 50,212 |
| Jan 3, 2025 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 414 | $11.98 | $5.0K | 48,773 |
| Jul 3, 2024 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 4,345 | $14.13 | $61.4K | 50,563 |
| Jul 3, 2024 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 1,160 | $14.13 | $16.4K | 49,187 |
| Apr 3, 2024 | Bettington Timothy J | SEE REMARKS | Sell | 23,557 | $15.43 | $363.5K | 106,387 |
| Apr 1, 2024 | Modi Rajeev A. | SEE REMARKS | Sell | 7,509 | $15.97 | $119.9K | 69,763 |
| Mar 5, 2024 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Sell | 11,012 | $15.99 | $176.1K | 1,356,455 |
| Mar 1, 2024 | Cabral Ramiro Martin | SEE REMARKS | Sell | 8,909 | $16.03 | $142.8K | 169,048 |
| Mar 1, 2024 | Correia de Simas Jose Manuel | SEE REMARKS | Sell | 3,642 | $16.03 | $58.4K | 49,768 |
| Mar 1, 2024 | de Brabander Ellen | SEE REMARKS | Sell | 9,774 | $16.03 | $156.7K | 114,886 |
| Mar 1, 2024 | Kinard David S | SEE REMARKS | Sell | 5,731 | $16.03 | $91.9K | 149,646 |
| Mar 1, 2024 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 1,921 | $16.03 | $30.8K | 54,908 |
| Mar 1, 2024 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 1,667 | $16.03 | $26.7K | 50,347 |
| Mar 1, 2024 | Modi Rajeev A. | SEE REMARKS | Sell | 3,616 | $16.03 | $58.0K | 77,272 |
ELAN Insiders
Similar Stocks to ELAN
ZTS
Zoetis Inc.
$117.47-0.31%
$51.80B
VTRS
Viatris Inc.
$14.70-0.73%
$17.15B
NBIX
Neurocrine Biosciences, Inc.
$127.75-0.23%
$13.07B
INDV
Indivior Pharmaceuticals Inc
$34.44+0.36%
$4.15B
SUPN
Supernus Pharmaceuticals, Inc.
$48.30-2.35%
$2.87B
PAHC
Phibro Animal Health Corporation
$54.56-2.81%
$2.19B
ANIP
ANI Pharmaceuticals, Inc.
$78.47-1.42%
$1.79B
PRGO
Perrigo Company plc
$11.57+0.74%
$1.61B